Drug Shortage Report for TEVA-PROCTOSONE
Report ID | 88222 |
Drug Identification Number | 02226383 |
Brand name | TEVA-PROCTOSONE |
Common or Proper name | PROCTOSONE |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | DIBUCAINE HYDROCHLORIDE HYDROCORTISONE FRAMYCETIN SULFATE ESCULIN |
Strength(s) | 5MG 5MG 10MG 10MG |
Dosage form(s) | OINTMENT |
Route of administration | RECTAL |
Packaging size | 15G |
ATC code | C05AA |
ATC description | AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2019-07-02 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2021-01-14 |
Company comments | Alternate material supplier to be sourced and validated. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v15 | 2021-01-14 | French | Compare |
v14 | 2021-01-14 | English | Compare |
v13 | 2019-12-19 | French | Compare |
v12 | 2019-12-19 | English | Compare |
v11 | 2019-12-12 | French | Compare |
v10 | 2019-12-12 | English | Compare |
v9 | 2019-10-03 | French | Compare |
v8 | 2019-10-03 | English | Compare |
v7 | 2019-09-05 | French | Compare |
v6 | 2019-09-05 | English | Compare |
v5 | 2019-08-29 | French | Compare |
v4 | 2019-08-29 | English | Compare |
v3 | 2019-07-03 | English | Compare |
v2 | 2019-07-02 | French | Compare |
v1 | 2019-07-02 | English | Compare |
Showing 1 to 15 of 15